Keryx Biopharmaceuticals

Akili Securities Corp, based in Boston, MA, is pioneering a new era of cognitive medicine by developing engaging digital treatments for individuals with cognitive impairments. Their flagship product, EndeavorOTC, is a game-based treatment clinically proven to enhance attention and focus specifically in adults with ADHD, available on both the App Store and Google Play. In addition to EndeavorOTC, Akili has introduced EndeavorRx, the first FDA-authorized prescription video game treatment for children with ADHD. By merging advanced neuroscience with cutting-edge technology and video game entertainment, Akili is redefining the way cognitive medicine is designed, delivered, and experienced. Generated from the website

Tokai Pharmaceuticals is a biopharmaceutical company based in Boston, MA. The company is focused on developing novel treatments for cancer and other serious diseases. Utilizing cutting-edge research and innovative technologies, Tokai Pharmaceuticals is dedicated to advancing the field of oncology and improving patient outcomes through targeted therapies. Generated from their business information

Atea Pharmaceuticals Inc., based in Boston, MA, is a forward-thinking organization specializing in a variety of industries, including healthcare, education, and public sector consulting. The company is committed to redefining global consulting through industry-focused expertise and a customer-centric approach, leveraging technology, data, and innovative strategies to address complex business challenges. With a strong emphasis on corporate social responsibility, Atea is dedicated to fostering diversity and inclusion within its workforce, while also engaging in meaningful community service initiatives. Their commitment to advancing client readiness and operational efficiency is reflected in their tailored solutions and insightful research in the sectors they serve. Generated from the website